Providing further insight into the mechanisms through which K17 acts in ACD, it was found that K17 translocates into the nucleus of activated keratinocytes, facilitating activation of STAT3 and downstream CCL20 production as well as T cell trafficking. Here, STAT3 is linked to granular corneal dystrophy type II.